Brentuximab Vedotin vs Montelukast

Brentuximab Vedotin vs Montelukast: Overview

This comparison examines the pharmacological differences between Brentuximab Vedotin and Montelukast.

Mechanism of Action

Montelukast: Selective leukotriene D4 receptor antagonist.

Pharmacokinetics

Half-life: Montelukast — 2.7-5.5 hours.

Chemical Properties

Molecular Formula: Montelukast — C35H36ClNO3S.

Molecular Weight: Montelukast — 586.1800 g/mol.

Type: Brentuximab Vedotin — Antibody drug conjugate; Montelukast — Small molecule.